Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey
Authors:
- 1 March 2014
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 16 (3) , 145-149
Abstract
Background: Little is known about the frequencies and types of nonmetabolic complications occurring in type 1 diabetes patients being treated by modern insulin pump therapy (continuous subcutaneous insulin infusion [CSII]), when recorded by standardized questionnaire rather than clinical experience. Subjects and Methods: A self-report questionnaire was completed by successive subjects with type 1 diabetes attending an insulin pump clinic, and those with a duration of CSII of ≥6 months were selected for analysis ( n =92). Questions included pump manufacturer, insulin, infusion set type and duration of use, frequency of infusion set and site problems, pump malfunctions, and patient-related problems such as weight change since starting CSII. Results: Median (range) duration of CSII was 3.3 (0.5–32.0) years, and mean±SD duration of infusion set use was 3.2±0.7 (range 2–6) days. The commonest infusion set problems were kinking (64.1% of subjects) and blockage (54.3%). Blockage was associated with >3 days of use of infusion sets plus lispro insulin in the pump (relative risk [95% confidence interval], 1.71 [1.03–2.85]; P =0.07). The commonest infusion site problem was lipohypertrophy (26.1%), which occurred more often in those with long duration of CSII (4.8 [2.38–9.45] vs. 3.0 [1.50–4.25] years; P =0.01). Pump malfunction had occurred in 48% of subjects (43% in the first year of CSII), with “no delivery,” keypad, and battery problems commonly occurring. Although some patients reported weight gain (34%) and some weight loss (15%) on CSII, most patients (51%) reported no change in weight. Conclusions: Pump, infusion set, and infusion site problems remain common with CSII, even with contemporary technology.Keywords
This publication has 22 references indexed in Scilit:
- Insulin-Pump Therapy for Type 1 Diabetes MellitusNew England Journal of Medicine, 2012
- Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusionJournal of Diabetes and its Complications, 2010
- Insulin Pump Therapy Guidelines for Successful OutcomesThe Diabetes Educator, 2009
- Psychological Aspects in Continuous Subcutaneous Insulin Infusion: A Retrospective StudyThe Journal of Psychology, 2009
- Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapyDiabetes/Metabolism Research and Reviews, 2009
- Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusionDiabetic Medicine, 2008
- Dermatological Complications of Continuous Subcutaneous Insulin Infusion in Children and AdolescentsThe Journal of Pediatrics, 2008
- Use of Insulin Pump Therapy in the Pediatric Age-GroupDiabetes Care, 2007
- Technical risks with subcutaneous insulin infusionDiabetes & Metabolism, 2006
- Diabetic Lipohypertrophy Delays Insulin AbsorptionDiabetes Care, 1984